EAM Global Investors’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-41,922
| Closed | -$4.89M | – | 87 |
|
|
2025
Q1 | $4.89M | Buy |
+41,922
| New | +$4.89M | 1.33% | 24 |
|
|
2023
Q1 | – | Sell |
-21,288
| Closed | -$1.64M | – | 96 |
|
|
2022
Q4 | $1.64M | Sell |
21,288
-16,930
| -44% | -$1.31M | 0.42% | 121 |
|
|
2022
Q3 | $1.71M | Hold |
38,218
| – | – | 0.45% | 105 |
|
|
2022
Q2 | $1.46M | Buy |
+38,218
| New | +$1.46M | 0.36% | 140 |
|
|
2020
Q3 | – | Sell |
-18,569
| Closed | -$1.53M | – | 138 |
|
|
2020
Q2 | $1.53M | Sell |
18,569
-32,080
| -63% | -$2.64M | 0.69% | 72 |
|
|
2020
Q1 | $2.98M | Buy |
50,649
+10,443
| +26% | +$614K | 1.74% | 6 |
|
|
2019
Q4 | $4.16M | Sell |
40,206
-18,416
| -31% | -$1.9M | 1.66% | 6 |
|
|
2019
Q3 | $1.19M | Sell |
58,622
-778
| -1% | -$15.8K | 0.58% | 91 |
|
|
2019
Q2 | $1.53M | Sell |
59,400
-25,686
| -30% | -$662K | 0.65% | 73 |
|
|
2019
Q1 | $1.21M | Buy |
+85,086
| New | +$1.21M | 0.54% | 101 |
|